Adage Capital Partners
ELDN icon

Adage Capital Partners’s Eledon Pharmaceuticals ELDN Stock Holding History

Adage Capital Partners’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-409,759
Closed -$2.53M – 1048
2021
Q3 		$2.53M Sell
409,759
-443,449
-52% -$3.1M 0.01% 884
2021
Q2 		$6.75M Sell
853,208
-39,347
-4% -$371K 0.01% 783
2021
Q1 		$9.55M Hold
892,555
– – 0.02% 695
2020
Q4 		$13.7M Buy
+892,555
New +$17M 0.03% 519

Other funds holding ELDN

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Adage Capital Partners's ELDN Position: Q4 2021 in Review

Adage Capital Partners sold out of Eledon Pharmaceuticals (ELDN) in Q4 2021, closing a stake of 409,759 shares — an estimated $2.53M sold.

Adage Capital Partners first reported a position in ELDN in Q4 2020 and held it in 4 quarters. The position peaked at $13.7M in Q4 2020. 36 funds tracked by Wall St. Rank hold ELDN as of Q4 2021.

  • Adage Capital Partners reported no remaining Eledon Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Adage Capital Partners sold 409,759 Eledon Pharmaceuticals shares in Q4 2021, an estimated $2.53M.
  • Adage Capital Partners first reported a position in Eledon Pharmaceuticals in Q4 2020 and held it in 4 quarters.
  • Adage Capital Partners's Eledon Pharmaceuticals position peaked at $13.7M in Q4 2020.
  • 36 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q4 2021.

Based on Adage Capital Partners's 13F filing for Q4 2021, filed 14 Feb 2022.